These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16314631)

  • 41. Chemotherapy-induced normalization of FDG uptake by colorectal liver metastases does not usually indicate complete pathologic response.
    Tan MC; Linehan DC; Hawkins WG; Siegel BA; Strasberg SM
    J Gastrointest Surg; 2007 Sep; 11(9):1112-9. PubMed ID: 17623263
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of multiphase CT, FDG-PET and intra-operative ultrasound in patients with colorectal liver metastases selected for surgery.
    Wiering B; Ruers TJ; Krabbe PF; Dekker HM; Oyen WJ
    Ann Surg Oncol; 2007 Feb; 14(2):818-26. PubMed ID: 17136470
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detectability of liver metastases in malignant melanoma: prospective comparison of magnetic resonance imaging and positron emission tomography.
    Ghanem N; Altehoefer C; Högerle S; Nitzsche E; Lohrmann C; Schäfer O; Kotter E; Langer M
    Eur J Radiol; 2005 May; 54(2):264-70. PubMed ID: 15837408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Evaluation by FDG-PET of arterial infusion chemotherapy for unresectable metastatic liver tumor].
    Imamoto E; Naito Y; Kuchide M; Tomatsuri N; Yoshida N; Yoshikawa T; Kondo M; Kou T; Kunishima S; Taniguchi H
    Gan To Kagaku Ryoho; 2000 Oct; 27(12):1973-6. PubMed ID: 11086457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET.
    Rydzewski B; Dehdashti F; Gordon BA; Teefey SA; Strasberg SM; Siegel BA
    AJR Am J Roentgenol; 2002 Feb; 178(2):353-8. PubMed ID: 11804891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gadopentetate dimeglumine and FDG uptake in liver metastases of colorectal carcinoma as determined with MR imaging and PET.
    van Laarhoven HW; de Geus-Oei LF; Wiering B; Lok J; Rijpkema M; Kaanders JH; Krabbe PF; Ruers T; Punt CJ; van der Kogel AJ; Oyen WJ; Heerschap A
    Radiology; 2005 Oct; 237(1):181-8. PubMed ID: 16183932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
    Park JW; Kim JH; Kim SK; Kang KW; Park KW; Choi JI; Lee WJ; Kim CM; Nam BH
    J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.
    Kitagawa Y; Nishizawa S; Sano K; Ogasawara T; Nakamura M; Sadato N; Yoshida M; Yonekura Y
    J Nucl Med; 2003 Feb; 44(2):198-206. PubMed ID: 12571209
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatic cryotherapy and regional chemotherapy with or without resection for liver metastases from colorectal carcinoma: how many are too many?
    Yan DB; Clingan P; Morris DL
    Cancer; 2003 Jul; 98(2):320-30. PubMed ID: 12872352
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monitoring of response to pre-operative chemoradiation in combination with hyperthermia in oesophageal cancer by FDG-PET.
    Westerterp M; Omloo JM; Sloof GW; Hulshof MC; Hoekstra OS; Crezee H; Boellaard R; Vervenne WL; ten Kate FJ; van Lanschot JJ
    Int J Hyperthermia; 2006 Mar; 22(2):149-60. PubMed ID: 16754598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intermodality comparison between 3D perfusion CT and 18F-FDG PET/CT imaging for predicting early tumor response in patients with liver metastasis after chemotherapy: preliminary results of a prospective study.
    Kim DH; Kim SH; Im SA; Han SW; Goo JM; Willmann JK; Lee ES; Eo JS; Paeng JC; Han JK; Choi BI
    Eur J Radiol; 2012 Nov; 81(11):3542-50. PubMed ID: 22459347
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases.
    Wiering B; Ruers TJ; Oyen WJ
    Expert Rev Anticancer Ther; 2004 Aug; 4(4):607-13. PubMed ID: 15270664
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Positron emission tomography scanning is not superior to whole body multidetector helical computed tomography in the preoperative staging of colorectal cancer.
    Furukawa H; Ikuma H; Seki A; Yokoe K; Yuen S; Aramaki T; Yamagushi S
    Gut; 2006 Jul; 55(7):1007-11. PubMed ID: 16361308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review.
    de Geus-Oei LF; Vriens D; van Laarhoven HW; van der Graaf WT; Oyen WJ
    J Nucl Med; 2009 May; 50 Suppl 1():43S-54S. PubMed ID: 19403879
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of blood glucose levels on [18F]fluorodeoxyglucose (FDG) uptake in cancer: a PET study in liver metastases from colorectal carcinomas.
    Crippa F; Gavazzi C; Bozzetti F; Chiesa C; Pascali C; Bogni A; De Sanctis V; Decise D; Schiavini M; Cucchetti G; Bombardieri E
    Tumori; 1997; 83(4):748-52. PubMed ID: 9349315
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness of positron emission tomography for predicting chemotherapy response in colorectal cancer liver metastases.
    Glazer ES; Beaty K; Abdalla EK; Vauthey JN; Curley SA
    Arch Surg; 2010 Apr; 145(4):340-5; discussion 345. PubMed ID: 20404283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment monitoring with 18F-FDG PET in metastatic thymoma after 90Y-Dotatoc and selective internal radiation treatment (SIRT).
    Vasamiliette J; Hohenberger P; Schoenberg S; Diehl S; Dinter DJ; Marx A; Stroebel P; Strauss LG; Dimitrakopoulou-Strauss A
    Hell J Nucl Med; 2009; 12(3):271-3. PubMed ID: 19936342
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Use of 18F-FDG PET scan in the diagnosis of large liver neoplasms and in the evaluation of therapeutic effectiveness].
    Balabanova AA; Tiutin LA; Kostenikov NA; Tlostanova MS; Ryzskova DV; Prozorovskiĭ KV
    Vopr Onkol; 2008; 54(4):434-8. PubMed ID: 18942396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of molecular imaging to differentiate liver metastasis of colorectal cancer metastasis from neuroendocrine tumor origin.
    Desai K; Watkins J; Woodward N; Quigley AM; Toumpanakis C; Bomanji J; Caplin M
    J Clin Gastroenterol; 2011 Jan; 45(1):e8-11. PubMed ID: 20861802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.